Misfolding proteins bring caution for gene therapies for haemophilia
US researchers have discovered a link between protein misfolding and liver cancer, that could help improve gene therapy for haemophilia.
List view / Grid view
US researchers have discovered a link between protein misfolding and liver cancer, that could help improve gene therapy for haemophilia.
Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
US researchers, using new machine learning techniques have developed a virtual molecular library of “words” that encode commands to kill cancer cells.
Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
Researchers have detected Alongshan virus (ALSV) for the first time in Switzerland in ticks.
Discover key target cells for immunotherapy, how cells and processes can be assessed in vitro and approaches for selecting the most appropriate assay.
This article outlines three innovative studies that use nanotechnology to deliver a new immunotherapy approach towards cancers.
Blocking a process called trogocytosis could enhance the ability of CAR T-cell therapies to treat cancer, according to research led by University of Pennsylvania scientists. In this Q&A, Dr Serge Fuchs, Elizabeth and William Whitney Clark Professor of Oncology at the University of Pennsylvania School of Veterinary Medicine, US, discusses…
US researchers have shown that CAR-T therapy can be used to eliminate unwanted cells that cause autoimmunity.
Measure protein, DNA and RNA in FFPE tissue samples using rigorously IHC validated CST antibodies on the NanoString® nCounter® platform.
Canadian researchers underwent a modelling study to explore optimal allocation of vaccines against monkeypox virus (MPXV), that prioritises vaccines to larger networks with more initial infections and greater potential for spread is best.
In this ebook are articles on immune checkpoint inhibitors and enhancing CAR T-cell therapies.
Join our experts as they discuss factors causing variability issues in organoids and how to avoid them.
This ebook details Euretos’ approach to predicting novel gene-disease associations including a case study on Multiple Sclerosis GWAS and drug targets.
US scientists have new insight into how heart cells enable unhealthy growth, and identify a new target to intervene against heart disease.